Five-year review of corticosteroid duration and complications in the management of immune checkpoint inhibitor-related diarrhoea and colitis in advanced melanoma

BACKGROUND: Immune-related diarrhoea/colitis (ir-D/C) is a common adverse event of immune checkpoint inhibitor (ICI) therapy. Guidelines recommend corticosteroid (CS) treatment; however, the average treatment duration for ir-D/C remains poorly defined. METHODS: All advanced melanoma patients treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Favara, David M, Spain, Lavinia, Au, Lewis, Clark, James, Daniels, Ella, Diem, Stefan, Chauhan, Dharmisha, Turajlic, Samra, Powell, Nick, Larkin, James M, Yousaf, Nadia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348326/
https://www.ncbi.nlm.nih.gov/pubmed/32641348
http://dx.doi.org/10.1136/esmoopen-2019-000585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348326/
https://www.ncbi.nlm.nih.gov/pubmed/32641348
http://dx.doi.org/10.1136/esmoopen-2019-000585

Ejemplares similares